
Fidelio Medical
Predictive diagnostics for primary care clinical decisions.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | N/A | €20.0k | Grant |
Total Funding | 000k |
EUR | 2022 | 2023 | 2024 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 47 % | 30 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
% profit margin | 8 % | 23 % | (66 %) |
EV | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Fidelio Medical develops digital diagnostic solutions using proprietary technology to support clinical decisions and targeted therapies in primary care settings. The company is focused on creating accessible and affordable screening and monitoring programs for conditions like anemia and iron deficiency. Its advanced digital platform is engineered to deliver real-time diagnoses during medical visits, aiming to improve early detection and facilitate prompt access to treatment.
The stated mission is to strengthen primary healthcare systems by addressing the diagnostic needs of vulnerable populations. By enabling early and effective care, Fidelio Medical seeks to enhance patient quality of life, reduce healthcare expenditures, and mitigate health disparities. The platform is designed to be a comprehensive tool for diagnosing common and treatable conditions in a single step.
Keywords: predictive diagnostics, primary care, digital diagnostics, clinical decision support, targeted therapy, health screening, patient monitoring, anemia, iron deficiency, real-time diagnosis, accessible healthcare, vulnerable populations, health equity, medical technology